Natalizumab: Pneumonitis and peripheral blood eosinophilia: case report

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948042/
http://dx.doi.org/10.1007/s40278-022-12270-9
_version_ 1784674581859008512
collection PubMed
description
format Online
Article
Text
id pubmed-8948042
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-89480422022-03-25 Natalizumab: Pneumonitis and peripheral blood eosinophilia: case report Reactions Weekly Case Report Springer International Publishing 2022-03-26 2022 /pmc/articles/PMC8948042/ http://dx.doi.org/10.1007/s40278-022-12270-9 Text en © Springer International Publishing AG 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Case Report
Natalizumab: Pneumonitis and peripheral blood eosinophilia: case report
title Natalizumab: Pneumonitis and peripheral blood eosinophilia: case report
title_full Natalizumab: Pneumonitis and peripheral blood eosinophilia: case report
title_fullStr Natalizumab: Pneumonitis and peripheral blood eosinophilia: case report
title_full_unstemmed Natalizumab: Pneumonitis and peripheral blood eosinophilia: case report
title_short Natalizumab: Pneumonitis and peripheral blood eosinophilia: case report
title_sort natalizumab: pneumonitis and peripheral blood eosinophilia: case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948042/
http://dx.doi.org/10.1007/s40278-022-12270-9

Ejemplares similares